WHO resumes hydroxycholorquine trial after ‘threat’ queried
The World Health Organization, or WHO, said on Wednesday that it will resume trials of anti-malaria drug hydroxycholorquine as a potential treatment of COVID-19 after having previously announced a temporary ...